|
Apr 30
|
SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Healthcare Conference
|
|
Apr 23
|
SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024
|
|
Apr 23
|
SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in Africa
|
|
Apr 21
|
We Think SOPHiA GENETICS (NASDAQ:SOPH) Can Afford To Drive Business Growth
|
|
Apr 17
|
SOPHiA GENETICS Announces Unilabs is using its AI Technology to Detect Homologous Recombination Deficiency (HRD)
|
|
Apr 4
|
SOPHiA GENETICS and Strand Life Sciences Announce New Strategic Partnership
|
|
Apr 2
|
Laboratorio Barnafi-Krause is Live on SOPHiA DDM™
|
|
Mar 20
|
SOPHiA GENETICS Announces First Homologous Recombination Deficiency (HRD) Customer in Canada
|
|
Mar 15
|
SOPHiA GENETICS and The French Kidney Cancer Research Network (UroCCR) Publish Results from Multiyear Collaboration
|
|
Mar 9
|
SOPHiA GENETICS SA (NASDAQ:SOPH) Just Released Its Yearly Results And Analysts Are Updating Their Estimates
|
|
Mar 7
|
SOPHiA GENETICS to Present at the Barclays 26th Annual Global Healthcare Conference
|
|
Mar 6
|
SOPHiA GENETICS Full Year 2023 Earnings: EPS Misses Expectations
|
|
Mar 6
|
SOPHiA GENETICS SA (NASDAQ:SOPH) Q4 2023 Earnings Call Transcript
|
|
Mar 6
|
Q4 2023 Sophia Genetics SA Earnings Call
|
|
Mar 5
|
SOPHiA GENETICS Reports Fourth Quarter and Full Year 2023 Results
|
|
Jan 15
|
SOPHiA GENETICS and Karkinos Healthcare Forge Strategic Partnership to Advance Cancer Research in India
|
|
Jan 10
|
SOPHiA GENETICS Highlights Near-Term Growth Strategy at 42nd Annual J.P. Morgan Healthcare Conference
|
|
Dec 7
|
SOPHiA GENETICS Announces Expanded Suite of Liquid Biopsy Offerings
|
|
Nov 30
|
SOPHiA GENETICS Announces Expansion of Work with CHU de Nîmes
|
|
Nov 28
|
SOPHiA GENETICS Expands Relationship with Città della Salute e della Scienza di Torino
|